The CDC and the FDA are recommending an immediate pause in using the Johnson and Johnson single-dose COVID-19 vaccine due to concerns about clotting.
Six women developed a rare disorder involving blood clots within two weeks of being vaccinated. One of them died, and a second woman has been hospitalized in critical condition. Nearly 7 million people have already received Johnson and Johnson shots in the US, and about 9 million more doses have been shipped.